Biotia
Every round on record, with the sources behind each and the investors on them.
LATEST ROUND
Funding round
$9M · 2026-10-01
RAISED ON RECORD · USD
$9M
across 1 round on record · $19.4M to date, as reported
INVESTORS
11
no lead named
SOURCES
Every round on record, with the sources behind each and the investors on them.
5 sources
The company release calls it an oversubscribed financing; GenomeWeb calls it private financing, while AlleyWatch calls it Venture funding. The more specific round article supports “private financing.”
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $9M $19.4M financing total | 2026-10-01 | not stated | No recent discussion |
5 sources [ VERIFIED · CORRECTED ] read against 4 of 5 sources
The company release calls it an oversubscribed financing; GenomeWeb calls it private financing, while AlleyWatch calls it Venture funding. The more specific round article supports “private financing.” | ||||
Biotia builds clinical metagenomic diagnostic tests and pathogen-genomics software for patients, clinicians, hospitals, laboratories, and public-health researchers facing hard-to-diagnose infections.
Checked against 10 sources today
Also named as backers in company research: Falcon III Ventures, Hyperplane Venture Capital, OCA Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Tau Ventures, SpringTide Ventures